This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Authoring team

The treatment of this condition must be started as soon as possible. If the diagnosis is suspected then treatment must be begun before the results of the culture studies are available. Different antimicrobial drugs are effective.

Seek expert advice.

Treatment guidelines are provided below:

Treatment must be given within 24 hours of onset.

First line: a standard gentamicin dose for severe sepsis or streptomycin: adults 1g IM bd; children, 15mg/kg/day IM bd.

If first line unsuitable then use ciprofloxacin (note 1): adults 400mg IV bd or 500-750 mg orally bd; children 15mg/kg IV bd or 20 mg/kg orally bd.

Milder cases use oral ciprofloxacin as above or doxycycline: adults, 100mg orally bd; children (>8 and <45 kg) 50 mg orally bd.

Note 1: not licensed for children under eight years of age or pregnant women.

Check summary of product characteristics before prescribing any medication described.

Check local microbioligical advice regarding antibiotic use and sensitivities.

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.